B6.Cg-Prnptm1Cwe Tg(Prnp*M128*D177N)FFI-10Rchi/Cnrm

Status

Available to order

EMMA IDEM:09930
International strain nameB6.Cg-Prnptm1Cwe Tg(Prnp*M128*D177N)FFI-10Rchi/Cnrm
Alternative nameTg(FFI-10+/+)/Prnp0/0
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolPrnptm1Cwe,
Gene/Transgene symbolPrnp

Information from provider

ProviderRoberto Chiesa
Provider affiliationNeuroscience, Istituto di Ricerche Farmacologiche Mario Negri
Genetic informationTransgenic mice expressing mouse prion protein (moPrP) carrying the D177N substitution that in humans is linked to fatal familial insomnia, under the control of the moPrP gene (Prnp) promoter.
Phenotypic informationHomozygous:
Neurological disease with sleep abnormalities, cognitive and motor dysfunction. Neurological signs become overt at approximately 300 days and mice reach a terminal stage at approximately 700 days (Bouybayoune et al., PLoS Pathog 11(4): e1004796, 2015).

Heterozygous:
Mild neurological signs. Mice live as long as nontransgenic controls (Bouybayoune et al., PLoS Pathog 11(4): e1004796, 2015).
Breeding historyThe Tg(FFI+/-)/Prnp+/+ founder was backcrossed with C57BL/6J/Prnp0/0 mice (EMMA strain EM:01723). After backcrossing for 10 generations, Tg(FFI+/+)Prnp0/0 mice were intercrossed to produce Tg(FFI+/+)/Prnp0/0 mice. Homozygous mice are maintained by intercrossing.
References
  • Transgenic fatal familial insomnia mice indicate prion infectivity-independent mechanisms of pathogenesis and phenotypic expression of disease.;Bouybayoune Ihssane, Mantovani Susanna, Del Gallo Federico, Bertani Ilaria, Restelli Elena, Comerio Liliana, Tapella Laura, Baracchi Francesca, Fernández-Borges Natalia, Mangieri Michela, Bisighini Cinzia, Beznoussenko Galina V, Paladini Alessandra, Balducci Claudia, Micotti Edoardo, Forloni Gianluigi, Castilla Joaquín, Fiordaliso Fabio, Tagliavini Fabrizio, Imeri Luca, Chiesa Roberto, ;2015;PLoS pathogens;11;e1004796; 25880443
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisednot known

Information from EMMA

Archiving centreCNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

MGI phenotypes (allele matching)
  • reduced long term potentiation / MGI
  • abnormal CNS synaptic transmission / MGI
  • abnormal inhibitory postsynaptic potential / MGI
  • abnormal inhibitory postsynaptic currents / MGI
  • behavior/neurological phenotype / MGI
  • decreased brain copper level / MGI
  • tremors / MGI
  • abnormal cerebellum morphology / MGI
  • decreased Purkinje cell number / MGI

Literature references

  • Transgenic fatal familial insomnia mice indicate prion infectivity-independent mechanisms of pathogenesis and phenotypic expression of disease.;Bouybayoune Ihssane, Mantovani Susanna, Del Gallo Federico, Bertani Ilaria, Restelli Elena, Comerio Liliana, Tapella Laura, Baracchi Francesca, Fernández-Borges Natalia, Mangieri Michela, Bisighini Cinzia, Beznoussenko Galina V, Paladini Alessandra, Balducci Claudia, Micotti Edoardo, Forloni Gianluigi, Castilla Joaquín, Fiordaliso Fabio, Tagliavini Fabrizio, Imeri Luca, Chiesa Roberto, ;2015;PLoS pathogens;11;e1004796; 25880443

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).